India  

COVID-19: Bharat Biotech's Covaxin approved by Centre for children above 12 years? Government said THIS

DNA Monday, 10 May 2021
The tweet shared by PIB also shared a screenshot of the news that claimed that Covaxin has been approved for children.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Bharat Biotech responds to Delhi's Covaxin plea, says...|  Oneindia News

Bharat Biotech responds to Delhi's Covaxin plea, says...| Oneindia News 03:17

Covaxin's maker Bharat Biotech has refused to supply vaccine doses to Delhi, Deputy Chief Minister Manish Sisodia said today. Cong MP Rahul Gandhi hit out at the centre's push for positivity aid the covid crisis in India, calling it betrayal. Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19...

💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Amarnath Yatra cancelled due to Covid-19

The Shri Amarnathji Shrine Board (SASB), headed by Jammu & Kashmir LG Manoj Sinha, on Monday decided to keep the annual pilgrimage to the Amarnath cave shrine..
IndiaTimes

Record 69 lakh Covid vaccine doses administered on day one of revised guidelines

More than 69 lakh vaccine doses were administered across the country till Monday evening on the first day of the revised guidelines for Covid-19 vaccination..
IndiaTimes
Tokyo 2020 crowds capped at a maximum of 10,000 [Video]

Tokyo 2020 crowds capped at a maximum of 10,000

Crowds at this summer’s Olympic Games in Tokyo have been capped at 50 per cent of a venue’s capacity, up to a maximum of 10,000.Spectators will be asked to refrain from shouting or even talking loudly, and to travel directly to the venue and return home immediately afterwards. However, they are unlikely to be asked to prove they are negative for Covid-19, or fully vaccinated.

Credit: PA - Press Association STUDIO    Duration: 01:20Published

Jammu and Kashmir govt cancels Amarnath Yatra for second consecutive year due to COVID

The 56-day Amarnath Yatra was due to start simultaneously on both routes from June 28 and culminate on Raksha Bandhan, August 22.
DNA

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covid-19: WHO accepts expression of interest for Covaxin emergency use listing

Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of..
IndiaTimes

WHO accepts Bharat Biotech's Expression of Interest for Covaxin emergency use listing

The World Health Organisation (WHO) has accepted Bharat Biotech’s expression of interest (EoI) for the emergency use listing (EUL) of India's first..
IndiaTimes

Bharat Biotech, WHO pre-submission meeting on June 23: WHO

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use..
IndiaTimes

Fact Check: No newborn calf serum in Covaxin, Health Ministry and Bharat Biotech confirm

The final vaccine does not contain newborn calf serum at all as the calf serum is not an ingredient of the final vaccine product, Health Ministry said
DNA

Covaxin Covaxin Vaccine against COVID-19

Shocking! Bihar woman gets both Covaxin, Covishield shots in 5 minutes interval - what happened next, know here

If Devi continues to show no adverse symptoms, she will be tested for antibodies after 14 days, a senior health official at AIIMS Patna has said.
DNA
New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News [Video]

New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News

Several social media users including Congress members have been sharing an RTI report that details the "ingredients" used in the India-made Covid-19 vaccine. #Covaxin #CalfSerum #FactCheck

Credit: Oneindia    Duration: 02:00Published

You Might Like


Related videos from verified sources

Covid-19: Aiims Delhi to begin Covaxin clinical trials for Children from today | Oneindia News [Video]

Covid-19: Aiims Delhi to begin Covaxin clinical trials for Children from today | Oneindia News

The screening of children for clinical trials of Covaxin will start at AIIMS in Delhi from today, days after similar trials started at AIIMS in Patna. AIIMS Delhi will conduct clinical trials of the..

Credit: Oneindia     Duration: 01:24Published
Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms  | Oneindia News [Video]

Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News

Thousands of people including Covid patients evacuated because of Cyclone Tauktae from Gujarat and Maharashtra; Bharat Biotech said that the company manufactured Covaxin is effective against the..

Credit: Oneindia     Duration: 03:39Published
Chhattisgarh will receive 3.50 lakh doses of Covishield today [Video]

Chhattisgarh will receive 3.50 lakh doses of Covishield today

Health Minister of Chhattisgarh, TS Singh Deo on May 08 said the state government will receive 3.50 lakh doses of Covishield today and the further vaccination will go on with this. "We received 1.50..

Credit: ANI     Duration: 01:25Published

Related news from verified sources

ICMR: Covaxin found to be effective against Brazilian variant of virus too

The indigenously developed Covaxin is capable of fighting the Brazilian variant too, according to the latest study on Covid-19 vaccine. Earlier, Covaxin was...
IndiaTimes

Don’t fret if second dose delayed, no need to restart vaccine schedule, say experts

First-dose recipients of Covaxin don't need to restart their vaccination schedule if the gap between doses goes beyond the recommended 4-6 week interval, a top...
IndiaTimes

Vax shortage forces shutting of 100 Covaxin sites in Delhi

Hundred vaccination sites administering Covaxin to the 18-44 age-group, located at 17 schools, have been closed down by the Delhi government due to vaccine...
IndiaTimes Also reported by •Zee News